Greystone Research Associates is pleased to announce the publication of a new
market study. Autoinjectors to 2018: Devices, Therapeutics, Markets,
Strategies and Prospects is a comprehensive evaluation and analysis of the
technology, products and participants providing the driving force behind this
evolving segment of the drug delivery sector. The study is designed to provide
drug company decision makers, drug delivery developers, device designers,
healthcare marketers, and supply chain participants with a detailed
understanding of the economics, technologies, disease segments, and commercial
opportunities for autoinjectors designed to accept a prefilled syringe and
simplify the injection process for self-administration. Provider organization
business managers, healthcare administrators and investors will also benefit
from this study.
Converging Factors Driving the Growth of Autoinjectors
The administration of therapeutic drugs via injection is an indispensable
delivery method for numerous drugs critical to patient health and well-being.
Now this segment is evolving in response to changing patient populations, new
classes of powerful therapeutic drugs and healthcare administration
initiatives. For drugs developed for self-administration, autoinjectors have
been shown to provide a more user-friendly outer package and improved
compliance. While autoinjectors are sometimes designed to work with a
particular injectable product as a form of pharmaceutical branding, the
typical autoinjector is designed to fit one or more standard sizes of
prefilled disposable syringes. Until recently, autoinjectors were designed to
be reused. The reason was that the injectors were too expensive to be
successfully marketed as a throw-away device. Recent improvements in materials
technology and device design have led to the creation of a class of
autoinjectors that can be made economically in high production quantities,
opening the door for the disposable autoinjector, and providing expanded
opportunities for both patient and drug marketer.
Feature Summary
Provides detailed analysis of autoinjectors for injectable drug delivery,
and assesses key market segments, market dynamics and market demographics
Analyzes therapeutic demand drivers and evaluates commercial devices in
five key product segments
Analyzes design factors, material selection issues, technologies and
market development issues
Charts market data and forecasts to 2018
Profiles injectable drug and device participants, their product
development activities, business strategies, and corporate alliances and
affiliations
Assesses the importance of pharma-device alliances and design partnerships
on autoinjector commercialization and market access
Evaluates the impact of economic, technology, and regulatory factors
Methodology
Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.
Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.
About Greystone Associates
Greystone Associates is a medical technology consulting firm focused on the
areas of medical market strategy, product commercialization, venture
development, and market research. We assist medical and healthcare market
participants in achieving their business objectives through the creation of
detailed development strategies, product commercialization programs, and
comprehensive market and technology research and analysis.
Our market research publications are designed, researched and written to
provide timely and insightful information and data on focused market segments,
with the aim of providing market participants with the essential knowledge to
refine and execute their marketing plans and financial targets.
Table of Contents
Executive Summary
The Market Opportunity
Delivery Market Dynamics
The Economics of Injectable Drugs
What's Driving the Growth in Autoinjectors?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Autoinjectors - Commercial Devices
Manual injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Variable Dose Autoinjectors
Product Specific Autoinjectors
Autoinjector Device Design Factors
Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics
Autoinjector Drug Delivery - Key Therapeutic Sector Analysis
Anticoagulants
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Emergency Medicine
Hepatitis
Hematopoietics
Hormones
Reproductive Health
Market Factors
Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics
Company Profiles
「オートインジェクター：治療、市場、戦略、今後の展望」は2013年03月01日にGreystone Research Associatesより発行されました。 当レポートは税抜￥295,260より販売しています。
